Stress Urinary Incontinence Clinical Trial
Official title:
A Randomised Controlled Double-Blind Clinical Study To Evaluate The Safety And Performance Of Neuromuscular Electrical Stimulation (NMES) With The Neurotech Vital Device For The Treatment Of Stress Urinary Incontinence
Stress Urinary Incontinence (SUI) is described as an uncontrolled loss of urine which happens
when physical activities such as running, jumping and lifting etc are carried out or when
increased pressure to the bladder in everyday life is applied by simply sneezing or coughing.
There are various treatment options available - surgical operations, pelvic floor
exercises/muscle training and electrical stimulation. This study aims to prove that using the
Neurotech Vital device for 12 weeks can stimulate the pelvic floor muscles to strengthen and
tone them and in doing so improving stress urinary incontinence. We are comparing the
Neurotech Vital device with an altered Neurotech Vital device that does not give the same
stimulation treatment. There is a 50% chance of you receiving the altered device, if you do,
you will be offered the non-altered Neurotech vital device after your first 12 week treatment
programme. Both devices are identical in looks, but give different stimulations through the
skin contact electrodes.
The study involves wearing a device that includes a wired garment around the hip and bottom
area for a period of 30 minutes, 5 days out of 7, for 12 weeks. During this treatment,
electrical stimulation is passed through skin contact electrodes (large sticky black pads)
which causes the pelvic floor to contract and relax, without you having to do anything. This
treatment is not painful and is very similar to the workout you would get from relaxing and
contracting your pelvic floor muscles yourself, however the device produces a much stronger
contraction.
The study is open to females who have failed a 6 week exercise programme and have been
diagnosed with Stress Urinary Incontinence. It will take place at hospital uro-gynaecology
clinics/continence clinics across the United Kingdom. The study could last up to 16 months.
This study is being carried out to further prove that the Neurotech Vital device is an
effective way of treating stress urinary incontinence in female participants.The study will
look at the results of a 12 week treatment programme with the Neurotech Vital device compared
to the modified Neurotech Vital device. It will compare the following:
1. how much urine is lost in a standard 1 minute stress test carried out at the baseline
visit (start of the treatment) right through to visit 5 (end of the treatment - 12
weeks).
2. How much improvement is shown in the quality of life questionnaire (this is measured by
ticking questions which have scores attached to them and adding up the total score for
the questionnaire). This questionnaire asks questions on quality of life which is
affected by stress urinary incontinence.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04829357 -
Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System
|
||
Completed |
NCT05493735 -
Lidocaine for Pessary Check Pain Reduction
|
Phase 3 | |
Completed |
NCT04512053 -
A Phase 2 Study of TAS-303 in Female Patients With Stress Urinary Incontinence
|
Phase 2 | |
Active, not recruiting |
NCT06224335 -
Measurement of Intravaginal and Intra-abdominal Pressure and Pad Test During Sports Activities (SPORTVAGPRES)
|
||
Recruiting |
NCT05304312 -
The Role of Kegel Exercises Book to Improve Treatment in Stress Urinary Incontinence Women
|
N/A | |
Not yet recruiting |
NCT05527665 -
Sexual Fonction and Discomfort in Women After Midurethral Sling Surgery, Using PPSSQ
|
||
Not yet recruiting |
NCT04558762 -
Ten Years Follow-up After Insertion of a MUS (Mid Urethral Sling) Due to Stress Urinary Incontinence
|
||
Withdrawn |
NCT02524366 -
A Study of Transcorporal Versus Standard Artificial Urinary Sphincter Placement
|
N/A | |
Completed |
NCT01924728 -
Efficacy of Magnetic Stimulation for Stress Urinary Incontinence
|
N/A | |
Completed |
NCT01676662 -
Solace European Confirmatory Trial
|
N/A | |
Unknown status |
NCT01455779 -
Lyrette: Renewing Continence Objective and Subjective Efficacy Study
|
N/A | |
Terminated |
NCT01029106 -
Gynecare TVT Secur for the Management of Stress Urinary Incontinence (SUI)
|
N/A | |
Completed |
NCT01770691 -
Preliminary Performance Study of the New TIPI Device in the Prevention of Stress Urinary Incontinence
|
N/A | |
Withdrawn |
NCT00573703 -
Laparoscopic Burch Colposuspension Versus Transobturatory Tape for the Treatment of Female Urinary Stress Incontinence
|
Phase 4 | |
Completed |
NCT01123096 -
Is the Cough Stress Test Equivalent to the 24 Hour Pad Test in the Assessment of Stress Incontinence?
|
N/A | |
Completed |
NCT00234754 -
Trans-Obturator Tape Versus Trans-Vaginal Tape for Stress Urinary Incontinence in Women
|
N/A | |
Completed |
NCT00441454 -
Retropubic vs. Transobturator Tension-free Vaginal Tape
|
N/A | |
Completed |
NCT03985345 -
Prospective Evaluation of the Connected EMY Biofeedback Probe in the Management of Stress Urinary Incontinence.
|
N/A | |
Active, not recruiting |
NCT03671694 -
Laser Vaginal Treatment for SUI
|
N/A | |
Completed |
NCT04097288 -
Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects
|
Phase 1 |